What is Ionis Pharmaceuticals Inc?
, a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.43B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 21,410 shares $61k | 15,000 shares $148k |
| 3-6months | 15201,312 shares $16.1M | 220,000 shares $1.1M |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |